KOLINPHARMA®: has achieved the award as “Leader of growth 2023” for the fifth consecutive year
KOLINPHARMA®: has achieved the award as “Leader of growth 2023” for the fifth consecutive year
Even this year the company is one of 500 Italian enterprises that were distinguished for the major growth of turnover in the period of observation between 2018 and 2021 marking a CAGR of 15.93% turnover.
The study was born with the collaboration between “Il sole 24 Ore e Statista”, and analysed 8000 companies with a turnover superior of 100,000 Euro in 2018 and 1.5 million in 2021, which distinguished for high tax of growth about turnover, in terms of CAGR, achieved mainly at the organic level.
The ranking can be found online.
Even this year the company is one of 500 Italian enterprises that were distinguished for the major growth of turnover in the period of observation between 2018 and 2021 marking a CAGR of 15.93% turnover.
The study was born with the collaboration between “Il sole 24 Ore e Statista”, and analysed 8000 companies with a turnover superior of 100,000 Euro in 2018 and 1.5 million in 2021, which distinguished for high tax of growth about turnover, in terms of CAGR, achieved mainly at the organic level.
The ranking can be found online.
